VALISONE-G 0.1 %
BETAMETHASONE (BETAMETHASONE VALERATE) : 0.1 % GENTAMICIN (GENTAMICIN SULFATE) : 0.1 % · DIN 00232351 · BAUSCH HEALTH, CANADA INC.
Health Canada status: DORMANT
What is VALISONE-G?
VALISONE-G 0.1 % contains BETAMETHASONE (BETAMETHASONE VALERATE) : 0.1 % GENTAMICIN (GENTAMICIN SULFATE) : 0.1 %. It is listed in the Health Canada Drug Product Database under DIN 00232351, held by BAUSCH HEALTH, CANADA INC., supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as dormant, status dated 28-Jul-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is VALISONE-G used for?
VALISONE-G is indicated in the topical management of secondarily infected allergic or inflammatory dermatoses responsive to corticosteroid therapy, such as contact dermatitis, seborrheic dermatitis, neurodermatitis, intertrigo, exfoliative dermatitis, stasis dermatitis and psoriasis. It is also indicated for the treatment of the aforementioned conditions whenever the possibility of secondary infection is present by gram-positive or gram-negative bacteria including Streptococci, Staphylococcus and species of Pseudomonas, Aerobacter, Escherichia, and Klebsiella, which are susceptible organisms to the topical action of gentamicin.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00232351 |
|---|---|
| Brand name | VALISONE-G |
| Generic / active ingredient | BETAMETHASONE (BETAMETHASONE VALERATE) : 0.1 % GENTAMICIN (GENTAMICIN SULFATE) : 0.1 % |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 0.1 % |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07CC01 BETAMETHASONE AND ANTIBIOTICS |
| AHFS class | 84:04.04 ; 84:06.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 28-Jul-2022 |
| Original market date | 1972-12-31 00:00:00 |
How is it stored and handled?
Store at 15 to 30 °C.
How is it supplied?
Tubes of 30 g.
What can be used instead?
Other Canadian products sharing ATC code D07CC01 BETAMETHASONE AND ANTIBIOTICS. 1 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FUCIBET | 2 % | CREAM | LEO PHARMA INC | MARKETED | DIN 02474883 |
| DIPROGEN CREAM | 0.05 % | CREAM | MERCK CANADA INC | CANCELLED POST MARKET | DIN 00417262 |
| DIPROGEN OINTMENT | 0.05 % | OINTMENT | MERCK CANADA INC | CANCELLED POST MARKET | DIN 00417254 |
| VALISONE-G | 0.1 % | CREAM | BAUSCH HEALTH, CANADA INC. | DORMANT | DIN 00177016 |
Who else supplies BETAMETHASONE AND ANTIBIOTICS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BETAMETHASONE AND ANTIBIOTICS appears in 2437 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.